ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,665
0,15%
Bitcoin
58 266,56
0,05%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cabaletta Bio Inc (CABA)

  7. Cabaletta Bio Inc (CABA) Actualités

CABA Cabaletta Bio Inc

12,09
1,45 (13,57%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cabaletta Bio Inc CABA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
1,45 13,57% 12,09 01:44:26
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
10,60 10,555 12,69 12,41 10,645
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
21/3/202412:00GLOBECabaletta Bio Reports Fourth Quarter and Full Year 2023..
20/3/202412:00GLOBECabaletta Bio Announces FDA Granted Orphan Drug Designation..
04/3/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202414:00GLOBECabaletta Bio to Participate in Upcoming Investor..
14/2/202415:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202400:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:36EDGAR2Form 8-K - Current report
01/2/202422:30GLOBECabaletta Bio Announces FDA Granted Orphan Drug Designation..
31/1/202414:00GLOBECabaletta Bio to Participate in the Guggenheim Healthcare..
20/1/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202413:11EDGAR2Form 8-K - Current report
08/1/202413:00GLOBECabaletta Bio Receives Additional FDA Fast Track..
02/1/202414:00GLOBECabaletta Bio to Present at the 42nd Annual J.P. Morgan..
20/12/202302:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202312:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
28/11/202322:30GLOBECabaletta Bio to Participate in the 6th Annual Evercore ISI..
28/11/202320:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
21/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:16EDGAR2Form 144 - Report of proposed sale of securities
09/11/202313:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:12EDGAR2Form 8-K - Current report
09/11/202313:00GLOBECabaletta Bio Reports Third Quarter 2023 Financial Results..
06/11/202314:15BWCellares and Cabaletta Bio Partner to Evaluate Automated..
06/11/202313:55DJNCabaletta Bio Gets FDA OK to Study CABA-201 in Generalized..
06/11/202313:03EDGAR2Form 8-K - Current report
06/11/202313:00GLOBECabaletta Bio Receives FDA Clearance of CABA-201 IND..
30/10/202313:00GLOBECabaletta Bio to Participate in Multiple Upcoming Investor..
20/10/202301:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202322:03EDGAR2Form 144 - Report of proposed sale of securities
02/10/202313:38EDGAR2Form 8-K - Current report
02/10/202313:00GLOBECabaletta Bio Receives FDA Clearance of IND Application for..
20/9/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202322:23EDGAR2Form 144 - Report of proposed sale of securities
19/9/202314:00GLOBECabaletta Bio to Participate in Upcoming Investor..
05/9/202314:45EDGAR2Form 8-K - Current report
30/8/202314:00GLOBECabaletta Bio to Participate in Multiple Upcoming Investor..
22/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202314:03EDGAR2Form 8-K - Current report
22/8/202314:00GLOBECabaletta Bio and WuXi Advanced Therapies Announce Expansion..
21/8/202322:19EDGAR2Form 144 - Report of proposed sale of securities
10/8/202313:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/8/202313:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:16EDGAR2Form 8-K - Current report
10/8/202313:00GLOBECabaletta Bio Reports Second Quarter 2023 Financial Results..
24/7/202314:06EDGAR2Form 8-K - Current report
24/7/202314:00GLOBECabaletta Bio Appoints Global Commercial Leader Shawn..

Dernières Valeurs Consultées

NASDAQ
CABA
Cabaletta Bio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés